Alterity Therapeutics Health Care
Biotech Healthcare

$0.007 0.001 (16.67%)

High $0.01	Low $0.01	Trades 19	Turnover $1,131	Volume 188,484
30 June 2023 at 4:10pm

Market Cap (15-Sep) $95,047,680 (1,258th)	Close (30-Jun) $0.007 0 (0%)	Volume (30-Jun) 188,484	Shortsold (9-Sep) 250,836 (0.11%) (439th)
52w High $0.79	52w Low $0.350	P/E 10.33	EPS -0.11

Short Interest

ASIC data, 9 Sep 2026

% Shorted

0.11% 0.00

vs 0.11% prior report

Most Shorted Rank

439th

of 689 shorted ASX stocks

Peak Short

1.18%

Jan 2024

Days to Cover

0.9

at 50d avg vol

View full short position history →

	Subject
	ATH ATH Ann: Change in substantial holding
	1 (current) 2 3
	ATH ATH Ann: ATH434 Phase 2 clinical launched in Europe
	ATH ATH Ann: Extension to regain NASDAQ minimum bid price compliance
	ATH ATH Ann: Change in substantial holding
	ATH ATH Ann: Appendix 4C and Quarterly Cash Flow Report
	ATH ATH Ann: Change in substantial holding
	ATH ATH Ann: First Patient dosed in ATH434 Phase 2 Clinical Trial
	ATH ATH Ann: Alterity receives a $4.1 million R&D Tax Refund
	ATH ATH Ann: Notification of cessation of securities - ATH
	ATH ATH Ann: Regulatory Approval to Proceed with Phase 2 Trial in Italy
	ATH ATH Ann: Alterity to Present at Life Sciences Investor Forum
	ATH ATH Ann: Alterity to present at GCFF Virtual Conference 2022
	ATH ATH Ann: Alterity Launches ATH434 Phase 2 Clinical Trial
	ATH ATH Ann: Alterity to Participate in the Benchmark Company Conference
	ATH ATH Ann: Change in substantial holding
	ATH ATH Ann: Appendix 4C and Quarterly Cash Flow Report
	ATH ATH Ann: UK Regulatory Authorisation to Proceed with Phase 2 Trial
	ATH ATH Ann: Presentation of bioMUSE Data at the AAN Annual Meeting
	ATH ATH Ann: Change in substantial holding
	ATH ATH Ann: Change in substantial holding
	ATH ATH Ann: Alterity to participate in Sachs Neuroscience Conference
	ATH ATH Ann: Investor Presentation
	ATH ATH Ann: Alterity to Present at the 34th Annual Roth Conference
	ATH ATH Ann: NASDAQ Non-Compliance Notice Received
	ATH ATH Ann: Half Yearly Report and Accounts
	ATH ATH Ann: New publication shows ATH434 rescues neurons in MSA model
	ATH ATH Ann: Appendix 4C and Quarterly Cash Flow Report
	ATH ATH Ann: Change in substantial holding
	ATH ATH Ann: Response to ASX Query
	ATH ATH Ann: Change in substantial holding
	ATH ATH Ann: New US Patent for Compounds to Treat Neurodegeneration
	ATH ATH Ann: Alterity to present at H.C. Wainwright Conference
	ATH ATH Ann: Final Director's Interest Notice x 2
	ATH ATH Ann: Notification of cessation of securities - ATH
	ATH ATH Ann: Alterity announces resignation of Non-Executive Directors
	ATH ATH Ann: Change in substantial holding
	ATH ATH Ann: Notification of cessation of securities - ATH
	ATH ATH Ann: First Regulatory Authorization to Proceed with Phase 2 Trial
	ATH ATH Ann: Notification regarding unquoted securities - ATH
	ATH ATH Ann: Change in substantial holding
	ATH ATH Ann: Change in substantial holding
	ATH ATH Ann: Alterity to present at upcoming investor conferences
	ATH ATH Ann: Results of Annual General Meeting
	ATH ATH Ann: ATH Annual General Meeting Presentation
	ATH ATH Ann: Chairman's Address 2021 Annual General Meeting
	ATH ATH Ann: Alterity presents at American Autonomic Society Meeting
	ATH ATH Ann: New Data Advance ATH434 as Neurodegeneration treatment
	ATH ATH Ann: Change in substantial holding
	ATH ATH Ann: Appendix 4C and Quarterly Cash Flow Report
	ATH ATH Ann: Expanded ATH434 Phase 2 Clinical Development Program

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Imugene

IMU

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

End of Day Prices

Date	Close	Volume	Change
15-Sep	$0.43	295,450	-0.03 (5.56%)
14-Sep	$0.45	315,197	-0.01 (2.17%)
11-Sep	$0.46	472,291	-0.02 (4.17%)
10-Sep	$0.48	514,427	-0.03 (4.95%)
09-Sep	$0.51	212,950	+0.02 (4.12%)
08-Sep	$0.49	233,334	-0.01 (2.02%)
07-Sep	$0.50	22,827	-0.01 (1.00%)
04-Sep	$0.50	103,119	-0.01 (0.99%)
03-Sep	$0.51	66,054	-0.02 (2.88%)
02-Sep	$0.52	368,675	+0.02 (4.00%)
01-Sep	$0.50	67,171	-0.01 (0.99%)
31-Aug	$0.51	130,784	-0.02 (2.88%)
28-Aug	$0.52	258,525	+0.01 (1.96%)
27-Aug	$0.51	646,962	+0.01 (2.00%)
26-Aug	$0.50	833,301	-0.01 (1.96%)
4 up, 11 down, and 0 flat days

Alterity Therapeutics Health Care
Biotech Healthcare

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Alterity Therapeutics Health Care Biotech Healthcare

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Alterity Therapeutics Health Care
Biotech Healthcare